Betaine And Homocysteine — The Methyl Donor Nobody Mentions
Quick Read Your body has two separate systems for recycling homocysteine, an amino acid that builds up after you eat
We write a new article on supplements every day , all detailed, with citations.
Once a week we send an email containing a list of the last 7 days articles. Please sign up and also feel free to share the articles with friends and family who you think might benefit.
Simon Parrott – Vitacuity Ltd
Zinc deficiency is remarkably common in older adults, affecting roughly one in three to one in two people aged 65 and over. Zinc sits in the junctions between brain cells where it helps control how well they communicate and form memories. When zinc runs low, this communication becomes sluggish and inflammation in the brain increases, both linked to dementia.
A major study of nearly 70,000 people found that zinc deficiency was associated with a 34% increased risk of developing dementia, with a clear dose-response pattern: the lower the zinc, the higher the risk. In people who already have dementia, zinc deficiency was linked to a 54% higher risk of death within one year. The biological mechanisms behind these findings are well understood in animal studies and appear plausible in humans.
What we don’t yet have are randomised controlled trials proving that zinc supplements prevent dementia. The evidence is compelling enough to act on, however. Getting zinc from foods like red meat, shellfish, seeds and legumes is ideal, and a modest daily supplement of 10 to 15 mg is safe, inexpensive and sits well within safe limits for most people.
Verdict: The evidence linking zinc deficiency to cognitive decline is substantial and the risk is common, making sensible zinc supplementation a practical, low-cost step worth considering as part of brain health, though formal trials confirming prevention benefits are still needed.
What if one of the most common nutritional shortfalls in middle age is quietly raising your risk of dementia, and almost nobody is talking about it? Most people know to think about omega-3, or vitamin D, or even B12 when it comes to brain health. But zinc? It barely features in the conversation. Yet when Vitacuity’s research team analysed over 1.77 million papers and pulled together the most relevant studies on this topic, a surprisingly consistent picture emerged: zinc deficiency is remarkably common after 40, and the evidence linking it to cognitive decline is more compelling than most people, including most GPs, realise.
This isn’t a story about a miracle mineral. It’s a story about a quiet, correctable deficiency that a significant proportion of older adults are living with right now, often without knowing it.
To understand why zinc matters for cognition, you need to understand what it’s actually doing inside your brain, and it turns out, quite a lot.
Zinc is one of the most abundant trace elements in the brain. It sits in specialised compartments in the synapses, the tiny junctions where neurons communicate with each other, where it plays a direct role in memory formation and learning. When your neurons fire, zinc is released into the synapse, where it acts as a kind of volume knob for brain signals, helping regulate the strength and efficiency of those connections. This process, called synaptic plasticity, is essentially the biological basis of how we form memories and adapt our thinking [12].
But here’s where it gets interesting, and a little complicated. Zinc operates within a very narrow optimal range in the brain. Too little zinc and synaptic signalling becomes sluggish; neurons can’t communicate properly, and the structures underpinning memory begin to degrade. Too much zinc flooding into neurons, however, can itself become toxic, contributing to the kind of neurodegeneration seen in Alzheimer’s disease [12].
The body has an elegant system for managing this balance, proteins called metallothioneins that act like sponges, either releasing zinc when the brain needs it or mopping up excess. But as we age, this balancing act becomes harder to maintain [10, 12]. Zinc absorption declines. Dietary intake often drops. And the body’s regulatory systems become less efficient.
Separately, zinc plays a critical role in immune regulation. When zinc levels fall, a key inflammatory pathway called the NLRP3 inflammasome, think of it as the brain’s alarm system, becomes overactive. Chronic, low-level inflammation in brain tissue (neuroinflammation) is increasingly recognised as one of the central mechanisms driving Alzheimer’s disease and other dementias [9]. Zinc deficiency, in other words, may be quietly stoking that fire.
Before diving into what zinc deficiency does to the brain, it’s worth pausing on just how widespread this problem is, because the figures are startling.
A 2026 narrative review of micronutrient status in older adults, drawing on studies published in the previous five years, found that zinc deficiency affected between 31% and 49% of community-dwelling older adults [3, 14]. That’s roughly one in three to one in two people aged 65 and over, living independently and eating reasonably normally. In care homes and assisted-living facilities, the rates were even higher: 50–66% of residents were found to be zinc-deficient [3, 14].
These aren’t fringe populations. These are the people in your neighbourhood, your family, possibly you in 20 years.
The review identified several reasons why deficiency becomes more common with age: reduced dietary variety, lower caloric intake overall, polypharmacy (some medications interfere with zinc absorption), and simply the fact that zinc absorption efficiency decreases as we get older [3].
This matters because most of the cognitive decline research we’ll look at below was conducted in people aged 50 and over, a population that, based on these prevalence figures, has an uncomfortably high chance of being zinc-insufficient right now.
Evidence grade: Promising to Strong, prevalence data comes from multiple recent studies across different populations, though most focus on adults aged 65+. Data for the 40–64 age group is thinner.
The most striking piece of research in this area was published in *Frontiers in Nutrition* in 2025. Researchers used the TriNetX Research Network, a large US healthcare database, to conduct a retrospective cohort study of adults aged 50 and over who had undergone serum zinc testing between 2010 and 2023 [1, 6].
After careful propensity score matching (a statistical technique that ensures you’re comparing like with like, controlling for age, other health conditions, medications and other factors), they ended up with 34,249 patients in each group, zinc-deficient versus zinc-normal, and tracked them for three years to see who went on to develop dementia.
The finding: zinc deficiency was associated with a 34% increased risk of new-onset dementia (adjusted hazard ratio 1.34, 95% confidence interval 1.17–1.53) [1, 6].
Crucially, the researchers also found a dose-response relationship, meaning the lower the zinc level, the higher the dementia risk. This kind of pattern is important in epidemiology, because it suggests the association isn’t just statistical noise or coincidence; it has a coherent biological shape to it.
The researchers concluded that zinc deficiency represents “an independent, modifiable risk factor for new-onset dementia” and called for randomised controlled trials to establish whether correcting deficiency can reduce that risk [1].
What does “independent” mean here? It means that even after accounting for other factors that influence dementia risk, diabetes, cardiovascular disease, age, sex, other nutritional deficiencies, zinc deficiency still showed its own separate association with dementia. It wasn’t just a proxy for being generally unwell.
Evidence grade: Promising, this is a large, well-designed observational study with robust statistical controls. But it is still observational. It cannot prove that zinc deficiency *causes* dementia, only that the two are strongly associated. Randomised controlled trials are the next essential step.
A 2026 matched cohort study published in *Frontiers in Nutrition* pushed the story further, looking not at people who might develop dementia, but at people who already had it [2, 13].
Using the same TriNetX database, researchers identified 1,241 matched pairs of dementia patients, half with zinc deficiency, half with normal zinc levels, and tracked outcomes over one year.
The results were sobering. Among zinc-deficient dementia patients, 10.1% died within one year, compared to 6.8% of those with normal zinc. That translates to a hazard ratio of 1.54, a 54% higher risk of death within 12 months [2, 13].
Zinc-deficient patients also had significantly higher rates of sepsis, pneumonia, urinary tract infections and ICU admissions. Again, the researchers found a dose-response relationship, the more severe the deficiency, the worse the outcomes [2].
The authors were careful to note that this does not prove causation, it’s possible that zinc deficiency is a marker of being more seriously ill overall, rather than a direct cause of worse outcomes. But it is a striking signal, and it adds to the case that zinc status matters enormously in the context of cognitive decline and its downstream consequences.
Evidence grade: Promising, well-matched observational cohort study, large enough to be meaningful, but observational limitations apply. Causality not yet established.
The observational data is compelling, but it becomes significantly more convincing when you understand the biological mechanism underlying it.
A 2021 study published in the *Journal of Neuroscience* investigated how zinc deficiency interacts with one of the key drivers of Alzheimer’s pathology: the NLRP3 inflammasome [9].
The NLRP3 inflammasome is, in effect, the brain’s inflammatory alarm system. When it’s activated, it triggers a cascade of inflammatory signals that, if sustained, cause progressive damage to brain tissue. It’s one of the mechanisms researchers believe connects chronic inflammation to Alzheimer’s disease [9].
The study, which combined mouse model experiments with epidemiological analysis of human data, found several important things. In mice bred to develop Alzheimer’s-like pathology, a zinc-deficient diet accelerated memory deficits. Zinc deficiency also potentiated NLRP3 responses in immune cells including microglia (the brain’s resident immune cells), making the inflammatory response more aggressive. And in the human epidemiological component, zinc supplementation was associated with reduced risk and slower cognitive decline in people with Alzheimer’s disease and mild cognitive impairment [9].
Separately, a 2024 review in *Metallomics* explained the synaptic role in more detail: zinc released during neural firing is essential for synaptic plasticity, but as we age, the extracellular zinc pool in the hippocampus (the brain’s memory centre) rises, potentially reflecting a dysregulation of zinc balance, which itself contributes to neurodegeneration [12].
Evidence grade: Early stage to Promising, the mechanism is well-characterised in animal and cell models. The human epidemiological component in the 2021 study adds support, but the animal-to-human translation needs formal RCT confirmation.
One of the more fascinating studies in this area looked not at typical older adults, but at centenarians and the oldest-old, people aged 80 to over 100, in China’s Hainan Province [8].
Researchers measured trace elements in participants’ hair (a marker of longer-term mineral status) and assessed cognitive function. They found that hair zinc levels were significantly lower in those with age-related cognitive decline compared to those without. When all relevant variables were adjusted for, higher zinc was associated with a reduced likelihood of cognitive decline (odds ratio 0.988 per unit increase, meaning each increment in zinc was associated with lower odds of decline) [8].
The study involved 50 centenarians (median age 103) and 73 oldest-old adults (median age 90). Sample sizes are modest, but the population is extraordinary, these are people who have aged exceptionally well, and the observation that zinc status tracks with cognitive preservation in this group is intriguing [8].
Evidence grade: Early stage, small sample, cross-sectional design, and hair zinc as a proxy measure introduces uncertainty. But it adds a coherent thread to the broader picture.
One nuance worth understanding, because it’s genuinely important and sometimes misrepresented, is that the relationship between zinc and brain health is not simply “more is better.”
A 2018 paper in *Molecular Neurobiology* described a situation where amyloid-beta plaques (the protein clumps central to Alzheimer’s disease) actually sequester zinc from neurons, creating a paradox: whilst zinc accumulates around plaques in the brain, neurons themselves become functionally zinc-deficient [10]. This “functional zinc deficiency”, even when total body zinc might appear adequate, may contribute to cognitive decline through impaired synaptic signalling [10].
A 2014 mouse study added another layer: using a metal-regulating compound that redistributed zinc more efficiently within the hippocampus, researchers were able to rapidly improve memory performance, increase dendritic spine density (a measure of synaptic health), and enhance markers of neurogenesis [11]. The mechanism wasn’t simply adding more zinc, but optimising where and how it was distributed.
None of this changes the practical picture for most people, deficiency is far more common than excess, and supplementing at normal doses does not carry the risks associated with zinc toxicity. But it explains why this is a more sophisticated biological story than a simple deficiency-replacement narrative.
Evidence grade: Early stage, these are primarily animal and mechanistic studies. Important for understanding the biology; not yet confirmed in human clinical trials.
It’s important to be honest about the significant gaps in this research, because the picture, while compelling, is far from complete.
We don’t yet have randomised controlled trials confirming that zinc supplementation prevents dementia. The large cohort study [1] called explicitly for such trials to be conducted. Until they are, we cannot confirm causality, only association. The 34% increased risk figure is striking, but it’s possible that zinc deficiency is partly a marker of other conditions that drive dementia risk, rather than a direct cause.
The optimal dose and form of zinc supplementation for cognitive health has not been established. Most studies use serum zinc as a marker of deficiency, but serum zinc is an imperfect measure, it doesn’t fully reflect zinc status in tissues or the brain specifically [10].
The 40–50 age group is underrepresented. Most of the human research focuses on adults aged 65 and over. The question of how zinc status tracks between 40 and 65, and whether intervening during this “window” produces meaningful cognitive benefit decades later, remains largely unanswered [3].
The zinc paradox in Alzheimer’s disease adds complexity. Whilst deficiency appears harmful, some studies suggest that zinc handling around amyloid plaques is dysregulated in ways that go beyond simple deficiency [10, 12]. Whether supplementation helps, is neutral, or could in some circumstances be unhelpful in people who already have significant Alzheimer’s pathology is not yet clear.
The hair and fingernail trace element studies are small and exploratory. The centenarian study [8] and the 5-year Portuguese follow-up study [15] both have sample sizes of 50–73 people, limiting how much we can generalise from them.
What we can say with confidence is this: the weight of evidence points toward zinc deficiency being genuinely meaningful for brain health, deficiency is common in older adults, and the biological mechanisms are plausible and increasingly well-characterised. That’s enough to act on, thoughtfully.
Here’s how a sensible, well-informed person should think about this.
Zinc deficiency affects somewhere between a third and half of older adults living independently, and the research linking it to dementia risk is now substantial enough that ignoring it would be a mistake. A 34% increased dementia risk in a study of nearly 70,000 people is not a number you dismiss [1]. Neither is a 54% higher one-year mortality in dementia patients who are zinc-deficient [2].
The good news: zinc is a trace mineral, it’s inexpensive, well-tolerated at normal supplementation doses, and the risk of deficiency almost certainly outweighs the risk of supplementing sensibly.
Practical steps, based on what the evidence actually supports:
1. Eat zinc-rich foods as a priority. Red meat, shellfish (especially oysters, which are extraordinarily rich in zinc), seeds (pumpkin, hemp), legumes, nuts and wholegrains all contain meaningful zinc. If your diet regularly includes these foods, you may be fine. But if you’re eating less meat than you used to, following a plant-based or largely plant-based diet, or simply eating less as your appetite has decreased with age, your intake is probably lower than you think.
2. Consider a modest daily zinc supplement. The UK reference nutrient intake is 9.5 mg/day for men and 7 mg/day for women. A typical supplement dose of 10–15 mg/day is appropriate and well within safe limits. The upper tolerable intake level is 25 mg/day in the UK, so standard supplements sit comfortably below any concern. Unlike iron, which should only be supplemented if you know you’re deficient, zinc at standard doses is safe for most people and the risk of deficiency is common enough that supplementation is a practical, sensible default.
3. Be aware of absorption factors. Phytates in wholegrains and legumes can reduce zinc absorption, if your diet is high in these foods without animal protein, your effective zinc intake may be lower than it appears. This is particularly relevant for those eating plant-forward diets.
4. Think about this as part of a brain health system. Zinc doesn’t operate in isolation. The same review that highlighted zinc deficiency also identified vitamin D, magnesium and folate as commonly deficient in older adults [3, 14]. A quality multivitamin and mineral supplement covering these bases is a low-cost, practical foundation.
5. Testing is an option but not essential. Serum zinc can be tested, but as noted above it’s an imperfect measure, and it’s not routinely offered on the NHS. Given the safety profile of standard zinc supplementation and the high prevalence of deficiency, waiting for a test before acting is not the most practical approach for most people. Supplement sensibly, eat well, and consider testing if you have a specific concern.
The research isn’t complete, it never is. But the direction of travel is clear. Zinc deficiency is common, the brain needs zinc to function properly, and the human data linking deficiency to cognitive decline is increasingly hard to ignore. This is exactly the kind of modifiable risk factor that’s worth addressing now, not after the research is perfect.
[1] Association of zinc deficiency and risk of new-onset dementia: a retrospective cohort study (2025). *Frontiers in Nutrition*. DOI: 10.3389/fnut.2025.1666887 | https://pubmed.ncbi.nlm.nih.gov/41262731/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12624281/
[2] Association between zinc deficiency and adverse outcomes in patients with dementia: a matched cohort study (2026). *Frontiers in Nutrition*. DOI: 10.3389/fnut.2026.1801558 | https://pubmed.ncbi.nlm.nih.gov/41939182/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13046538/
[3] Micronutrient Status, Health Implications, and Assessment Approaches in Older Adults: A Narrative Review of Recent Studies (2026). *Life*. DOI: 10.3390/life16040570 | https://pubmed.ncbi.nlm.nih.gov/42073380/
[8] Hair Zinc and Chromium Levels Were Associated with a Reduced Likelihood of Age Related Cognitive Decline in Centenarians and Oldest-Old Adults (2023). *The Journal of Nutrition, Health & Aging*. DOI: 10.1007/s12603-023-2008-8 | https://pubmed.ncbi.nlm.nih.gov/37997723/
[9] Zinc Status Alters Alzheimer’s Disease Progression through NLRP3-Dependent Inflammation (2021). *Journal of Neuroscience*. DOI: 10.1523/JNEUROSCI.1980-20.2020 | https://pubmed.ncbi.nlm.nih.gov/33597269/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018890/
[10] Novel Defense by Metallothionein Induction Against Cognitive Decline: From Amyloid β1-42-Induced Excess Zn2+ to Functional Zn2+ Deficiency (2018). *Molecular Neurobiology*. DOI: 10.1007/s12035-018-0948-5 | https://pubmed.ncbi.nlm.nih.gov/29460269/
[11] A novel approach to rapidly prevent age-related cognitive decline (2014). https://pubmed.ncbi.nlm.nih.gov/24305557/
[12] Insight into brain metallothioneins from bidirectional Zn2+ signaling in synaptic dynamics (2024). *Metallomics*. DOI: 10.1093/mtomcs/mfae039 | https://pubmed.ncbi.nlm.nih.gov/39223100/
[14] Micronutrient Status, Health Implications, and Assessment Approaches in Older Adults: A Narrative Review of Recent Studies (2026). *Life*. DOI: 10.3390/life16040570 | https://pubmed.ncbi.nlm.nih.gov/42073380/
[15] Associations between Trace Elements and Cognitive Decline: An Exploratory 5-Year Follow-Up Study of an Elderly Cohort (2020). *International Journal of Environmental Research and Public Health*. DOI: 10.3390/ijerph17176051 | https://pubmed.ncbi.nlm.nih.gov/32825289/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503463/
This article is for informational purposes only and does not constitute medical advice. Food supplements should not be used as a substitute for a varied and balanced diet and healthy lifestyle. If you are pregnant, breastfeeding, taking medication or have a medical condition, consult your doctor before taking any supplement. These statements have not been evaluated by the Food and Drug Administration (FDA) or the Medicines and Healthcare products Regulatory Agency (MHRA). This product is not intended to diagnose, treat, cure, or prevent any disease.
Quick Read Your body has two separate systems for recycling homocysteine, an amino acid that builds up after you eat
Quick Read B vitamins become increasingly important for brain health after 40 because your body absorbs them less efficiently with
The nutrients that matter, the forms that work, and the claims to ignore.
